The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

Prior research has found that there may ... dwelling U.S. adults aged 71 years or older. The paper is published in the journal JAMA Ophthalmology. Scientists still do not know what causes dementia, ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Treating vision loss and lowering cholesterol could help reduce the risk of dementia, according to a new report.

Did you know that someone on this planet develops dementia every 3 seconds? In fact, in 2020, it was estimated that more than ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Sep. 5, 2024 — Research discovered a unique and promising avenue for diagnosing Alzheimer's disease (AD) earlier -- by analyzing AD biomarkers in blood -- so that the impacts of dementia can be ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...